Search

Your search keyword '"Topol, Eric J."' showing total 4,183 results
Start Over Author "Topol, Eric J."
4,183 results on '"Topol, Eric J."'

201. Physicians and the investment industry

Author

Topol, Eric J. and Blumenthal, David

Subjects
Company business management, Physicians -- Management, Conflict of interests (Agency)
Abstract

The study states that the relationship of physicians with financial entities is radically transformed with almost one of 10 US physicians currently engaged in a formal consultancy with the investment industry. The scope of the convergence between physicians and investment firms, the issues of conflict of interest, and propose recommendations for institutions and individuals is discussed.

Published
2005

202. Effects of a 5-lipoxygenase-activating protein inhibitor on biomarkers associated with risk of myocardial infarction: A randomized trial

Author

Hakonarson, Hakon, Andresdottir, Margret, Zink, Florian, Gudbjartsson, Daniel, Helgadottir, Anna, Thorvaldsson, Sverrir, Manolescu, Andrei, Jonsson, Asgeir, Thorgeirsson, Gestur, Sigurdsson, Axel, Andersen, Karl, Arnar, David O., Agnarsson, Uggi, Adalsteinsdottir, Asdis E., Gudmundsdottir, Hrefna, Einarsson, Atli, Gottskalksson, Gizur, Bjornsdottir, Halldora, Gudmundsson, Kolbeinn, Gulcher, Jeffrey, Topol, Eric J., Kristinsson, Arni, Hardarson, Thordur, Kristjansson, Kristleifur, Kong, Augustine, Stefansson, Kari, Thorgeirssonj, Gudmundur, and Gurney Mark

Subjects
Leukotrienes -- Research, Biological markers -- Research, Heart attack -- Risk factors, Heart attack -- Research, Leukotrienes -- Synthesis
Abstract

A study is conducted to determine the effect of an inhibitor of 5-lipoxygenase-activating protein (FLAP) on levels of biomarkers associated with myocardial infarction (MI) risk. It is concluded that in patients with specific at-risk variants of 2 genes in the leukotriene pathway, DG-031 led to significant and dose-dependent suppression of biomarkers that are associated with increased risk of MI events.

Published
2005

204. Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: A meta-analysis of randomized trials

Author

Luca, Giuseppe De, Suryapranata, Harry, Stone, Gregg W., Tcheng, James E., Werf, Frans Van de, Antoniucci, David, Neumann, Franz-Josef, Antman, Elliott M., and Topol, Eric J.

Subjects
Abciximab -- Dosage and administration, Abciximab -- Research, Heart attack -- Care and treatment, Heart attack -- Research
Abstract

Data for all randomized trials conducted with abciximab in ST-segment elevation myocardial infarction (STEMI) are combined. The results revealed that, when compared with the control group, adjunctive abciximab for STEMI is associated with a significant reduction in 30-day and long-term mortality in patients treated with primary angioplasty but not in those receiving fibrinolysis.

Published
2005

208. Preface

Author

Teirstein, Paul S., primary and Topol, Eric J., additional

Published
2012
Full Text
View/download PDF

209. A global view of atherothrombosis: Baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial

Author

Bhatt, Deepak L., Fox, Keith A., Hacke, Werner, Berger, Peter B., Black, Henry R., Boden, William E., Cacoub, Patrice, Cohen, Eric A., Creager, Mark A., Easton, J. Donald, Flather, Marcus D., Haffner, Steven M., Hamm, Christian W., Hankey, Graeme J., Johnston, S. Claiborne, Mak, Koon-Hou, Mas, Jean-Louis, Montalescot, Gilles, Pearson, Thomas A., Steg, P. Gabriel, Steinhubl, Steven R., Weber, Michael A., Booth, Joan, and Topol, Eric J.

Published
2005

210. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: The CAMELOT study: A randomized controlled trial

Author

Nissen, Steven E., Tuzcu, E. Murat, Libby, Peter, Thompson, Paul D., Ghali, Magdi, Garza, Dahlia, Berman, Lance, Shi, Harry, Buebendorf, Ethel, and Topol, Eric J.

Subjects
Coronary heart disease -- Research, Coronary heart disease -- Care and treatment, Cardiac patients -- Research, Heart -- Abnormalities, Heart -- Care and treatment
Abstract

The study aimed to compare the effects of amlodipine or enalapril against placebo on cardiovascular events in patients with coronary artery disease (CAD) is discussed. It is concluded that administration of amlodipine to patients with CAD and normal blood pressure resulted in reduced adverse cardiovascular events.

Published
2004

211. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes

Author

Rao, Sunil V., Harrington, Robert A., Newby, L. Kristin, Moliterno, David J., Topol, Eric J., Armstrong, Paul W., Granger, Christopher B., Pieper, Karen, Lindblad, Lauren, Califf, Robert M., and Stamler, Jonathan S.

Subjects
Coronary heart disease -- Research, Blood transfusion -- Patient outcomes, Blood transfusion -- Research
Abstract

The association between blood transfusion and mortality among patients with acute coronary syndromes who develop bleeding, anemia or both during their hospital course are determined. It was found that blood transfusion in the setting of acute coronary syndromes is associated with higher mortality and this relationship persists after adjustment for other predictive factors and timing of events.

Published
2004

212. Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/ IIIa blockade during percutaneous coronary revascularization

Author

Lincoff, Michael, Kleiman, Neal S., Kereikes, Dean J., Feit, Frederick, Bittl, John A., JaVahanian, Aleccjman, Daniel J., Sarenbock, Ian J., Cohen, David J., Spriggs, Douglas, Ebrahimi, Ramin, Keren, Gadi, Carr, Jeffrey, Cohen, Eric A., Betriu, Amadeo, Desmet, Walter, Rutsch, Wolfgang, Wilcox, Robert G., Feyter, Pim J.de, Vahanian, Alec, and Topol, Eric J.

Subjects
Coronary heart disease -- Research, Glycoproteins -- Research
Abstract

The efficacy of bivalirudin that remains comparable with that of heparin plus Gp IIb/IIIa blockade over six months and one year are described. The result indicates that long-term clinical outcome with bivalirudin and provisional Gp IIb/IIa blockade is comparable with that of heparin plus planned Gp IIb/IIa inhibition during contemporary percutaneous coronary intervention.

Published
2004

213. Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial

Author

Bhatt, Deepak and Topol, Eric J.

Subjects
Therapeutics -- Comparative analysis, Aspirin -- Health aspects, Aspirin -- Comparative analysis, Coronary heart disease -- Drug therapy, Homeopathy -- Materia medica and therapeutics, Homeopathy -- Comparative analysis, Health, Plavix (Medication) -- Comparative analysis, Plavix (Medication) -- Health aspects
Published
2004

217. Association of diabetes mellitus and glycemic control strategies with clinical outcomes after acute coronary syndromes

Author

McGuire, Darren K., Newby, L. Kristin, Bhapkar, Manjushri V., Moliterno, David J., Hochman, Judith S., Klein, Werner W., Weaver, W. Douglas, Pfisterer, Matthias, Corbalan, Ramon, Dellborg, Mikael, Granger, Chrisotpher B., Van De Werf, Frans, Topol, Eric J., and Califf, Robert M.

Subjects
Diabetics -- Health aspects, Diabetics -- Research, Coronary heart disease -- Patient outcomes, Coronary heart disease -- Risk factors, Diabetes -- Complications and side effects, Diabetes -- Patient outcomes, Health
Published
2004

226. Contributors

Author

Alpert, Joseph S., primary, Aroney, Con, additional, Aylward, Philip L.G., additional, Bansilal, Sameer, additional, Bardy, Gust H., additional, Barter, Philip, additional, Beller, George A., additional, Bellomo, Rinaldo, additional, Bhatti, Tandeep, additional, Blankenberg, Stefan, additional, Blythe, David, additional, Bradshaw, Pamela J., additional, Brieger, David, additional, Briffa, Tom, additional, Campbell, Terence J., additional, Cavender, Matthew A., additional, Chew, Derek P., additional, Chih, Sharon, additional, Cooke, Philip, additional, Damani, Samir, additional, Davis, Timothy, additional, Dhamija, Rajinder K., additional, Donnan, Geoffrey A., additional, Dowling, John T., additional, Echeverri, Jorge E., additional, Ee, Hooi C., additional, Eikelboom, John W., additional, El-Sherif, Nabil, additional, Elsik, Maros, additional, Finn, Judith, additional, Fox, Keith A.A., additional, Fuster, Valentin, additional, Gallus, Alexander, additional, Gersh, Bernard J., additional, Goldenberg, Ilan, additional, Golledge, Jonathan, additional, Grines, Cindy L., additional, Haïssaguerre, Michel, additional, Hamilton-Craig, Ian, additional, Hare, David L., additional, Hecht, Harvey S., additional, Hickling, Siobhan, additional, Hillman, David, additional, Ho, Kwok M., additional, Horowitz, John D., additional, Hung, Joseph, additional, Huynh, Luan Tan, additional, Jacobs, Ian, additional, Jaffe, Allan S., additional, Jamrozik, Konrad, additional, Jelinek, Michael, additional, Johnson, Nils P., additional, Julian, Desmond, additional, Kaye, David, additional, Keller, Till, additional, Keogh, Anne M., additional, Kritharides, Leonard, additional, Krum, Henry, additional, Kumar, Ashok, additional, Gould, K. Lance, additional, Langton, Paul, additional, Lennon, Mark J., additional, Lowe, Harry, additional, Macdonald, Peter, additional, Maeder, Micha T., additional, Maiorana, Andrew, additional, Marwick, Thomas H., additional, McCrohon, Jane, additional, Mond, Harry G., additional, Moss, Arthur J., additional, Mountain, David, additional, Muller, David, additional, Newman, Mark, additional, Nidorf, Mark, additional, Ohman, E. Magnus, additional, Pitt, Bertram, additional, Power, Bradley M., additional, Prasad, Abhiram, additional, Richards, David, additional, Robinson, James, additional, Ross, David L., additional, Schenck-Gustafsson, Karin, additional, Simpson, Marion A., additional, Sinnaeve, Peter R., additional, Sloman, Graeme, additional, Stein, Paul D., additional, Stobie, Paul, additional, Stone, Peter H., additional, Subbiah, Rajesh, additional, Taggart, David, additional, Thompson, Angus G., additional, Thompson, Peter L., additional, Thygesen, Kristian, additional, Toogood, Mark N., additional, Topol, Eric J., additional, Torre, Luke, additional, Van de Werf, Frans, additional, Weerasooriya, Rukshen, additional, White, Harvey, additional, Willson, Alexander B., additional, and Yusoff, Ian F., additional

Published
2011
Full Text
View/download PDF

229. Prognostic value of myeloperoxidase in patients with chest pain

Author

Brennan, Marie-Luise, Penn, Marc S., Lente, Frederick van, Nambi, Vijay, Shishehbor, Mehdi H., Aviles, Ronnier J., Goormastic, Marlene, Pepoy, Michael L., McErlean, Ellen S., Topol, Eric J., Nissen, Steven E., and Hazen, Stanley L.

Subjects
Peroxidase -- Health aspects, Heart attack -- Diagnosis
Abstract

The presence of an enzyme called myeloperoxidase in the blood may identify patients with chest pain who may be having a heart attack, according to a study of 604 patients. This blood test can be used in patients who have a negative troponin T test because myeloperoxidase can appear in the blood even if the heart is not damaged. Troponin T is another blood test used to diagnose a heart attack.

Published
2003

230. Prognostic importance of physical examination for heart failure in non-ST-elevation acute coronary syndromes: the enduring value of Killip classification

Author

Khot, Umesh N., Jia, Gang, Moliterno, David J., Lincoff, A. Michael, Khot, Monica B., Harrington, Robert A., and Topol, Eric J.

Subjects
Heart failure -- Health aspects, Heart attack -- Prognosis
Abstract

The Killip classification system can accurately predict which patients with a non-ST-segment heart attack may die within the following year, according to a study of 26,090 patients. Those in Killip class 3 or 4 had higher 30-day and six-month death rates than those in Killip class 1 or 2. The Killip classification is used to indicate a patient's degree of heart failure. Killip 1 or 2 indicates no heart failure or mild heart failure and Killip 3 or 4 indicates moderate to severe heart failure.

Published
2003

233. Sustained ventricular arrhythmias and mortality among patients with acute myocardial infarction: Results from the GUSTO-III trial

Author

Al-Khatib, Sana M., Stebbins, Amanda L., Califf, Robert M., Lee, Kerry L., Granger, Christopher B., White, Harvey D., Armstrong, Paul W., Topol, Eric J., and Ohman, E.Magnus

Subjects
Heart attack -- Physiological aspects, Heart attack -- Case studies, Ventricular fibrillation -- Physiological aspects, Ventricular fibrillation -- Case studies, Arrhythmia -- Diagnosis, Arrhythmia -- Care and treatment, Arrhythmia -- Case studies, Health
Published
2003

234. Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial

Author

Lincoff, A. Michael, Bittl, John A., Harrington, Robert A., Feit, Frederick, Kleiman, Neal S., Jackman, J. Daniel, Sarembock, Ian J., Cohen, David J., Spriggs, Douglas, Ebrahimi, Ramin, Keren, Gadi, Carr, Jeffery, Cohen, Eric A., Betriu, Amadeo, Desmet, Walter, Kereiakes, Dean J., Rutsch, Wolfgang, Wilcox, Robert G., Feyter, Pim J. de, Vahanian, Alec, and Topol, Eric J.

Subjects
Anticoagulants (Medicine) -- Evaluation, Transluminal angioplasty -- Complications, Blood clotting -- Prevention
Abstract

The drug bivalirudin may be as effective as heparin when used to prevent complications from coronary angioplasty, according to a study of 6,010 patients. Bivalirudin is an anticoagulant drug that can prevent blood clots from forming during coronary angioplasty.

Published
2003

236. Frequency, patient characteristics, and outcomes of mild-to-moderate heart failure complicating ST-segment elevation acute myocardial infarction: Lessons from 4 international fibrinolytic therapy trials

Author

Hasdai, David, Topol, Eric J., Kilaru, Rakhi, Battler, Alexander, Harrington, Robert A., Vahanian, Alec, Ohman, E. Magnus, Granger, Christopher B., Werf, Frans Van de, Simoons, Maarten L., O'Connor, Christopher M., and Holmes, David R., Jr.

Subjects
Outcome and process assessment (Health Care) -- Influence, Heart failure -- Influence, Heart failure -- Patient outcomes, Heart failure -- Research, Heart attack -- Patient outcomes, Heart attack -- Research, Health
Published
2003

239. Contributors

Author

Ackerman, Michael J., primary, Barnes, Peter J., additional, Becker, Richard, additional, Benjamin, Ivor J., additional, Boguski, Mark, additional, Bondy, Brigitta, additional, Breitbart, Roger E., additional, Brody, Jerome S., additional, Bullinger, Lars, additional, Butte, Atul, additional, Chung, Wendy K., additional, Cottrell, Susan E., additional, Cox, Nancy J., additional, Febbo, Phillip G., additional, Gerhard, Glenn S., additional, Ginsburg, Geoffrey S., additional, Goldstein, David B., additional, Grossman, Iris, additional, Haga, Susanne, additional, Holton, John, additional, Hood, Leroy, additional, Huang, Andrew T., additional, Johnson, Melissa, additional, Khoury, Muin, additional, Lawler, Sean, additional, Lee, Charles, additional, Levy, Samuel, additional, Alfredo Martínez, J., additional, McGrath, Kevin, additional, McHutchison, John, additional, Newby, L. Kristin, additional, Newgard, Christopher, additional, Noble, Paul, additional, Nussbaum, Robert L., additional, Pejovic, Tanya, additional, Plenge, Robert, additional, Quertermous, Thomas, additional, Rader, Daniel J., additional, Ramaswamy, Sridhar, additional, Rimsza, Lisa, additional, Ross, Jeffrey, additional, Shannon, M. Frances, additional, Shianna, Kevin, additional, Singleton, Andrew, additional, Snyderman, Ralph, additional, Stewart, Alison, additional, Thomas, Giovana, additional, Topol, Eric J., additional, Towbin, Jeffrey A., additional, Veenstra, Timothy D., additional, Veenstra, David L., additional, Weiner, Howard L., additional, Weiss, Scott T., additional, Wiesner, Georgia, additional, Wiggs, Janey L., additional, Wijmenga, Cisca, additional, Willard, Huntington F., additional, Woodcock, Janet, additional, Woods, Christopher, additional, and Yagil, Yoram, additional

Published
2010
Full Text
View/download PDF

244. Provisional glycoprotein IIb/IIIa blockade in a randomized investigation of bivalirudin versus heparin plus planned glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: Predictors and outcome in the Randomized Evaluation in Percutaneous coronary intervention Linking Angiomax to Reduced Clinical Events (REPLACE)–2 trial

Author

Exaire, J. Emilio, Butman, Samuel M., Ebrahimi, Ramin, Kleiman, Neal S., Harrington, Robert A., Schweiger, Marc J., Bittl, John A., Wolski, Kathy, Topol, Eric J., and Lincoff, A. Michael

Published
2006
Full Text
View/download PDF

245. Promise of combined low-molecular-weight heparin and platelet glycoprotein IIb/IIIa inhibition: results from Platelet IIb/IIIa Antagonist for the Reduction of Acute coronary syndrome events in a Global Organization Network B (PARAGON B)

Author

Mukherjee, Debabrata, Mahaffey, Kenneth W., Moliterno, David J., Harrington, Robert A., Yadav, Jay S., Pieper, Karen S., Gallup, Dianne, Dyke, Christopher, Roe, Matthew T., Berdan, Lisa, Lauer, Michael S., Manttari, Matti, White, Harvey D., Califf, Robert M., and Topol, Eric J.

Subjects
Heart attack -- Drug therapy, Unstable angina -- Drug therapy, Anticoagulants (Medicine) -- Evaluation, Health
Published
2002

246. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial.

Author

Steinhubl, Steven R., Berger, Peter B., Mann, J. Tift, III, Fry, Edward T.A., DeLago, Augustin, Wilmer, Charles, and Topol, Eric J.

Subjects
Angioplasty, Coronary heart disease -- Drug therapy, Anticoagulants (Medicine) -- Evaluation
Abstract

Patients who will be having angioplasty for coronary artery disease may benefit from taking the anticoagulant drug clopidogrel before the operation. This was the conclusion of a study of 2,116 patients who took the drug 3 to 24 hours before the operation or at the time of the operation. All patients also took aspirin, which also prevents blood clot formation.

Published
2002

247. Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial

Author

Lincoff, A. Michael, Califf, Robert M., Van de Werf, Frans, Willerson, James T., White, Harvey D., Armstrong, Paul W., Guetta, Victor, Gibler, W. Brian, Hochman, Judith S., Bode, Christoph, Vahanian, Alec, Steg, P. Gabriel, Ardissino, Diego, Savonitto, Stefano, Bar, Frist, Sadowski, Zygmunt, Betriu, Amadeo, Booth, Joan E., Wolski, Kathy, Waller, Michael, and Topol, Eric J.

Subjects
Heart attack -- Drug therapy, Thrombolytic therapy -- Evaluation, Anticoagulants (Medicine) -- Evaluation
Abstract

Combining an anticoagulant with a thrombolytic drug does not reduce long-term death rates in heart attack patients compared to a thrombolytic drug alone. This was the conclusion of a study of 16,453 heart attack patients who received a thrombolytic drug only or a thrombolytic and an anticoagulant. Thrombolytic drugs break down blood clots whereas anticoagulants prevent blood from clotting.

Published
2002

249. Contributors

Author

Ackerman, Michael J., primary, Anderson, Matthew L., additional, Andreotti, Felicita, additional, Annex, Brian H., additional, Antonellis, Anthony, additional, Artemov, Dmitri, additional, Bain, James R., additional, Barnes, Peter J., additional, Barnholtz-Sloan, J.S., additional, Becker, Richard C., additional, Benjamin, Ivor J., additional, Billings, Paul R., additional, Body, Simon C., additional, Boguski, Mark, additional, Bonassi, Stefano, additional, Bondy, Brigitta, additional, Bos, J. Martijn, additional, Breitbart, Roger E., additional, Brody, Jerome, additional, Brown, Matthew P., additional, Bullinger, Lars, additional, Burgess, Shawn C., additional, Butte, Atul J., additional, Carey, David J., additional, Carlson, George, additional, Celedón, Juan C., additional, Chandrasekharan, Subhashini, additional, Chang, Wing C. (John), additional, Chen, Yan, additional, Chiocca, Antonio, additional, Chow, Theresa Puifun, additional, Chung, Wendy K., additional, Cook-Deegan, Robert, additional, Corella, Dolores, additional, Cottrell, Susan, additional, Cox, Nancy J., additional, Crawford, Nigel P.S., additional, Cuticchia, A. Jamie, additional, Deforce, Dieter, additional, Deng, Mario C., additional, Devi, Gayathri, additional, deVos, Theo, additional, Distler, Juergen, additional, Dohner, Harmut, additional, Dokun, Ayotunde O., additional, Edbrooke, Mark R., additional, Edelman, Lucas B., additional, Elewaut, Dirk, additional, Epstein, Charles J., additional, Fanous, Ayman H., additional, Febbo, Phillip G., additional, Feezor, Robert J., additional, Feng, Yonmei, additional, Földes-Papp, Zeno, additional, Fujinaka, Hidehiko, additional, Galas, David J., additional, Garrison, Louis, P., additional, Gerhard, Glenn S., additional, Ginsburg, Geoffrey S., additional, Gjertsen, Bjorn T., additional, Glass, Michael, additional, Goldstein, David B., additional, Gordon, Erynn S., additional, Gosnell, Tucker, additional, Grass, Peter, additional, Green, Eric D., additional, Grossman, Iris, additional, Gwinn, Marta, additional, Haefliger, Carolina, additional, Haga, Susanne B., additional, Hall, Per, additional, Hare, Joshua M., additional, Hariri, Ahmad, additional, Heath, James R., additional, Hegele, Robert A., additional, Heidecker, Bettina, additional, Hislop, Shona, additional, Hoffman, Eric P., additional, Holton, John, additional, Hood, Leroy, additional, Huang, Andrew T., additional, Huang, Erich S., additional, Hubbard, Carlos A., additional, Hunter, Kent, additional, Hyland, Courtney, additional, Ihm, Chunhwa, additional, Ilkayeva, Olga, additional, Irizarry, Rafael, additional, Jain, Shushant, additional, Johnson, Melissa D., additional, Kantoff, Philip W., additional, Kathiresan, Sekar, additional, Kathuria, Hasmeena, additional, Kawamoto, Kensaku, additional, Keyser, Filip De, additional, Khalid, Asif, additional, Khoury, Muin, additional, Kingsmore, Stephen F., additional, Kittleson, Michelle M., additional, Koshy, Beena T., additional, Krishnan, Ranga, additional, Krouse, Robert S., additional, Kundra, Vikas, additional, Lai-Goldman, Myla, additional, Lakhani, Vipul, additional, Langer, Robert, additional, Lawler, Sean E., additional, Lee, Inyoul, additional, Lee, Charles, additional, Lee, Arthur S., additional, Leong, Stanely, additional, Lesche, Ralf, additional, Levy, Samuel, additional, Liu, Edison T., additional, Lobach, David F., additional, Lorens, James B., additional, Lusis, Aldons J., additional, Lyerly, H. Kim, additional, Madamanchi, Nageswara R., additional, Martinez, J. Alfredo, additional, Masignani, Vega, additional, McGrath, Kevin, additional, McHutchison, John, additional, Middleton, Frank, additional, Mielants, Herman, additional, Muehlbauer, Michael J., additional, Müller-Ladner, Ulf, additional, Nelson, Mark A., additional, Neri, Monica, additional, Netea, Mihai, additional, Newby, L. Kristin, additional, Newgard, Christopher B., additional, Ng, Maggie, additional, Noble, Paul W., additional, Ntziachristos, Vasilis, additional, Nussbaum, Robert L., additional, O'Donoghue, Meghan B., additional, Odunsi, Kunle, additional, Olden, Kenneth, additional, Ommen, Steve R., additional, Ordovas, Jose M., additional, Patarca, Roberto, additional, Patel, Jeetendra, additional, Patel, K., additional, Pato, Carlos N., additional, Pato, Michele T., additional, Pejovic, Tanja, additional, Perin, Noah C., additional, Pham, Michael, additional, Plenge, Robert M., additional, Plum, Achim, additional, Podgoreanu, Mihai V., additional, Pollack, Jonathan R., additional, Pollex, Rebecca L., additional, Price, Nathan D., additional, Quertermous, Thomas, additional, Quintana, Francisco J., additional, Raby, Benjamin A., additional, Rader, Daniel J., additional, Ramaswamy, Sridhar, additional, Rammensee, Hans-Georg, additional, Ramsey, Scott D., additional, Rappuoli, Rino, additional, Rifai, Nader, additional, Rimsza, Lisa, additional, Rogers, Yu-Hui, additional, Roses, Allen D., additional, Ross, Jeffrey S., additional, Roubenoff, Ronenn, additional, Runge, Marschall S., additional, Scheuner, Maren T., additional, Schuster, Matthias, additional, Schwartz, David A., additional, Schwinn, Debra A., additional, Seng, Chia Kee, additional, Shackel, Nicholas A., additional, Shannon, M. Frances, additional, Sherry, A. Dean, additional, Shi, Jiaqi, additional, Shianna, Kevin, additional, Shnayder, Yelizaveta, additional, Singleton, Andrew B., additional, Slavin, T.P., additional, Smith, Desmond J., additional, Snoeckx, Rikkert L., additional, Snyderman, Ralph, additional, Spira, Avrum, additional, Spraggs, Colin F., additional, Stevens, Robert D., additional, Stewart, Nicolas A., additional, Stewart, Alison, additional, Stewart, F., additional, Strausberg, Robert L., additional, Szyf, Moshe, additional, Tan, Weihong, additional, Tepper, Robert I., additional, Tettelin, Hervé, additional, Thomas, Giovana R., additional, Thompson, John D., additional, Thongboonkerd, Visith, additional, Topol, Eric J., additional, Towbin, Jeffrey A., additional, Bodegraven, Ad A. van, additional, Van Den Bogaert, Kris, additional, Van den Bosch, Filip, additional, Vatta, Matte, additional, Veenstra, Timothy D., additional, Veenstra, David L., additional, Vendrov, Aleksandr E., additional, Verfaillie, Catherine M., additional, Walley, Nicole M., additional, Wang, Ling, additional, Weale, Mike, additional, Weinblatt, Michael E., additional, Weiner, Howard L., additional, Weiss, Scott T., additional, Weissleder, Ralph, additional, Wells, Samuel A., additional, Wenner, Brett R., additional, Wiechers, Ilse R., additional, Wiesner, Georgia L., additional, Wiggs, Janey L., additional, Wijmenga, Cisca, additional, Willard, Huntington F., additional, Wilson, James M., additional, Wivel, Nelson A., additional, Wohlgemuth, Jay, additional, Woodcock, Janet, additional, Woods, Christopher W., additional, Woon, Paula W., additional, Yagil, Chana, additional, Yagil, Yoram, additional, Yamamoto, Tadashi, additional, Yao, Gang, additional, Yee, Andrew J., additional, Yoo, Hyuntae, additional, You, Y. Nancy, additional, Yu, Li-Rong, additional, Zagury, Jean-François, additional, Zimmern, Ron, additional, and Züchner, Stephan, additional

Published
2009
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results